Today’s Top Three in Pharma 032009 posted on March 20, 2009FDA panel recommends approval of J&J/Bayer anti-clotting drug - Government health advisers said Thursday the benefits of an experimental anticlotting drug from Johnson & Johnson outweigh its …Continue Reading about Today’s Top Three in Pharma 032009 →